| Type |
Details |
Score |
| Publication |
| First Author: |
Kedmi R |
| Year: |
2022 |
| Journal: |
Nature |
| Title: |
A RORγt(+) cell instructs gut microbiota-specific T(reg) cell differentiation. |
| Volume: |
610 |
| Issue: |
7933 |
| Pages: |
737-743 |
|
•
•
•
•
•
|
| Allele |
| Name: |
ectonucleotide pyrophosphatase/phosphodiesterase 1; tiptoe walking |
| Allele Type: |
Spontaneous |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Enpp1/Enpp1 |
| Background: |
Jcl:ICR-Enpp1 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhang J |
| Year: |
2019 |
| Journal: |
Diabetologia |
| Title: |
DOC2B promotes insulin sensitivity in mice via a novel KLC1-dependent mechanism in skeletal muscle. |
| Volume: |
62 |
| Issue: |
5 |
| Pages: |
845-859 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
222
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yarwood S |
| Year: |
2006 |
| Journal: |
Biochem Soc Trans |
| Title: |
The GAP1 family of GTPase-activating proteins: spatial and temporal regulators of small GTPase signalling. |
| Volume: |
34 |
| Issue: |
Pt 5 |
| Pages: |
846-50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kupzig S |
| Year: |
2009 |
| Journal: |
Mol Cell Biol |
| Title: |
The ability of GAP1IP4BP to function as a Rap1 GTPase-activating protein (GAP) requires its Ras GAP-related domain and an arginine finger rather than an asparagine thumb. |
| Volume: |
29 |
| Issue: |
14 |
| Pages: |
3929-40 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kupzig S |
| Year: |
2006 |
| Journal: |
J Biol Chem |
| Title: |
GAP1 family members constitute bifunctional Ras and Rap GTPase-activating proteins. |
| Volume: |
281 |
| Issue: |
15 |
| Pages: |
9891-900 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fukuda M |
| Year: |
2003 |
| Journal: |
J Biol Chem |
| Title: |
Slp4-a/granuphilin-a inhibits dense-core vesicle exocytosis through interaction with the GDP-bound form of Rab27A in PC12 cells. |
| Volume: |
278 |
| Issue: |
17 |
| Pages: |
15390-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang J |
| Year: |
1999 |
| Journal: |
J Biol Chem |
| Title: |
Novel rabphilin-3-like protein associates with insulin-containing granules in pancreatic beta cells. |
| Volume: |
274 |
| Issue: |
40 |
| Pages: |
28542-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tsuboi T |
| Year: |
2006 |
| Journal: |
Mol Biol Cell |
| Title: |
The Slp4-a linker domain controls exocytosis through interaction with Munc18-1.syntaxin-1a complex. |
| Volume: |
17 |
| Issue: |
5 |
| Pages: |
2101-12 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chapman ER |
| Year: |
2002 |
| Journal: |
Nat Rev Mol Cell Biol |
| Title: |
Synaptotagmin: a Ca(2+) sensor that triggers exocytosis? |
| Volume: |
3 |
| Issue: |
7 |
| Pages: |
498-508 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Vasquez JK |
| Year: |
2014 |
| Journal: |
Biochemistry |
| Title: |
Lateral diffusion of proteins on supported lipid bilayers: additive friction of synaptotagmin 7 C2A-C2B tandem domains. |
| Volume: |
53 |
| Issue: |
50 |
| Pages: |
7904-13 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dai Y |
| Year: |
2011 |
| Journal: |
J Biol Chem |
| Title: |
Ca2+-dependent monomer and dimer formation switches CAPRI Protein between Ras GTPase-activating protein (GAP) and RapGAP activities. |
| Volume: |
286 |
| Issue: |
22 |
| Pages: |
19905-16 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
Munc13 proteins constitute a family of three highly homologous molecules (Munc13-1, Munc13-2 and Munc13-3) with homology to Caenorhabditis elegans Unc-13. Munc13 proteins contain a phorbol ester-binding C1 domain and two C2 domains, which are Ca2+/phospholipid binding domains. Sequence analyses have uncovered two regions called Munc13 homology domains 1 (MHD1) and 2 (MHD2) that are arranged between two flanking C2 domains. MHD1 and MHD2 domains are present in a wide variety of proteins from Arabidopsis thaliana, C. elegans, Drosophila melanogaster (Fruit fly), Mus musculus (Mouse), Rattus norvegicus (Rat) and Homo sapiens (Human), some of which may function in a Munc13-like manner to regulate membrane trafficking [].The MHD1 and MHD2 domains are predicted to be α-helical []. Some proteins known to contain MHD1 and MHD2 domains are listed below:Mammalian Munc13-1. It is specifically targeted to presynaptic active zones and has a central priming function in synaptic vesicle exocytosis from glutaminergic synapses.Mammalian Munc13-2. It plays a role in vesicle maturation during exocytosis as a target of the diacylglycerol second messenger pathway.Mammalian Munc13-3. It probably plays a role in vesicle maturation during exocytosis as a target of the diacylglycerol second messenger pathway.Mammalian Munc13-4. It is predominantly expressed in lung where it is localized to goblet cells of the bronchial epithelium and to alveolar type II cells, both of which are cell types with secretory function.C. elegans Unc-13. It may form part of a signal transduction pathway, transducing the signal from diacylglycerol to effector functions.Mammalian BAI1-associated protein 3 (BAP3), which exhibits the typical Munc13-like domain structure with two C2 domains flanking the MHD1 and MHD2 domains, but which lack the long N terminuswith the C1 domain.Animal calcium-dependent activator proteins for secretion (CAPSs), regulators of large dense-core vesicle secretion. They contain only a MHD1 domain and are otherwise unrelated to Munc13 proteins.A. thaliana hypothetical proteins with MHD1 and MHD2 domains but without C1 and C2 domains.Saccharomyces cerevisiae uncharacterised protein YOR296W, where MHD1 and MHD2 enclose a central C2 domain. YOR296W is presumably involved in bud formation.Schizosaccharomyces pombe hypothetical protein C11E3.02c in chromosome I, where MHD1 and MHD2 enclose a central C2 domain.This entry represents the Munc13 homology domain 1. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
Mammalian uncoordinated homology 13 (Munc13) proteins constitute a family of three highly homologous molecules (Munc13-1, Munc13-2 and Munc13-3) with homology to Caenorhabditis elegans Unc-13. Munc13 proteins contain a phorbol ester-binding C1 domain and two C2 domains, which are Ca2+/phospholipid binding domains. Sequence analyses have uncovered two regions called Munc13 homology domains 1 (MHD1) and 2 (MHD2) that are arranged between two flanking C2 domains. MHD1 and MHD2 domains are present in a wide variety of proteins from Arabidopsis thaliana, C. elegans, Drosophila melanogaster (Fruit fly), Mus musculus (Mouse), Rattus norvegicus (Rat) and Homo sapiens (Human), some of which may function in a Munc13-like manner to regulate membrane trafficking [].The MHD1 and MHD2 domains are predicted to be α-helical []. Some proteins known to contain MHD1 and MHD2 domains are listed below:Mammalian Munc13-1. It is specifically targeted to presynaptic active zones and has a central priming function in synaptic vesicle exocytosis from glutaminergic synapses.Mammalian Munc13-2. It plays a role in vesicle maturation during exocytosis as a target of the diacylglycerol second messenger pathway.Mammalian Munc13-3. It probably plays a role in vesicle maturation during exocytosis as a target of the diacylglycerol second messenger pathway.Mammalian Munc13-4. It is predominantly expressed in lung where it is localized to goblet cells of the bronchial epithelium and to alveolar type II cells, both of which are cell types with secretory function.C. elegans Unc-13. It may form part of a signal transduction pathway, transducing the signal from diacylglycerol to effector functions.Mammalian BAI1-associated protein 3 (BAP3), which exhibits the typical Munc13-like domain structure with two C2 domains flanking the MHD1 and MHD2 domains, but which lack the long N terminus with the C1 domain.Animal calcium-dependent activator proteins for secretion (CAPSs), regulators of large dense-core vesicle secretion. They contain only a MHD1 domain and are otherwise unrelated to Munc13 proteins.A. thaliana hypothetical proteins with MHD1 and MHD2 domains but without C1 and C2 domains.Saccharomyces cerevisiae uncharacterised protein YOR296W, where MHD1 and MHD2 enclose a central C2 domain. YOR296W is presumably involved in bud formation.Schizosaccharomyces pombe hypothetical protein C11E3.02c in chromosome I, where MHD1 and MHD2 enclose a central C2 domain.This entry represents the Munc13 homology domain 2. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Carninci P |
| Year: |
2000 |
| Journal: |
Genome Res |
| Title: |
Normalization and subtraction of cap-trapper-selected cDNAs to prepare full-length cDNA libraries for rapid discovery of new genes. |
| Volume: |
10 |
| Issue: |
10 |
| Pages: |
1617-30 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hwang JI |
| Year: |
2005 |
| Journal: |
Biochem J |
| Title: |
Molecular cloning and characterization of a novel phospholipase C, PLC-eta. |
| Volume: |
389 |
| Issue: |
Pt 1 |
| Pages: |
181-6 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
402
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
189
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xu J |
| Year: |
2017 |
| Journal: |
Elife |
| Title: |
Mechanistic insights into neurotransmitter release and presynaptic plasticity from the crystal structure of Munc13-1 C1C2BMUN. |
| Volume: |
6 |
|
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Arendt CW |
| Year: |
2002 |
| Journal: |
Curr Opin Immunol |
| Title: |
Protein kinase C-theta;: signaling from the center of the T-cell synapse. |
| Volume: |
14 |
| Issue: |
3 |
| Pages: |
323-30 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bauer B |
| Year: |
2001 |
| Journal: |
J Biol Chem |
| Title: |
Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells. |
| Volume: |
276 |
| Issue: |
34 |
| Pages: |
31627-34 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bauer B |
| Year: |
2000 |
| Journal: |
Eur J Immunol |
| Title: |
T cell expressed PKCtheta demonstrates cell-type selective function. |
| Volume: |
30 |
| Issue: |
12 |
| Pages: |
3645-54 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jin H |
| Year: |
2007 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. |
| Volume: |
104 |
| Issue: |
30 |
| Pages: |
12353-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
von Poser C |
| Year: |
2001 |
| Journal: |
Eur J Cell Biol |
| Title: |
Synaptotagmin 13: structure and expression of a novel synaptotagmin. |
| Volume: |
80 |
| Issue: |
1 |
| Pages: |
41-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jahn JE |
| Year: |
2010 |
| Journal: |
Exp Mol Pathol |
| Title: |
Exogenous expression of synaptotagmin XIII suppresses the neoplastic phenotype of a rat liver tumor cell line through molecular pathways related to mesenchymal to epithelial transition. |
| Volume: |
89 |
| Issue: |
3 |
| Pages: |
209-16 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Andersson SA |
| Year: |
2012 |
| Journal: |
Mol Cell Endocrinol |
| Title: |
Reduced insulin secretion correlates with decreased expression of exocytotic genes in pancreatic islets from patients with type 2 diabetes. |
| Volume: |
364 |
| Issue: |
1-2 |
| Pages: |
36-45 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhao Y |
| Year: |
2007 |
| Journal: |
J Biol Chem |
| Title: |
Phosphoinositide 3-kinase C2alpha links clathrin to microtubule-dependent movement. |
| Volume: |
282 |
| Issue: |
2 |
| Pages: |
1249-56 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Falasca M |
| Year: |
2007 |
| Journal: |
J Biol Chem |
| Title: |
The role of phosphoinositide 3-kinase C2alpha in insulin signaling. |
| Volume: |
282 |
| Issue: |
38 |
| Pages: |
28226-36 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Clarke JH |
| Year: |
2007 |
| Journal: |
Biochem Soc Symp |
| Title: |
Type II PtdInsP kinases: location, regulation and function. |
|
| Issue: |
74 |
| Pages: |
149-59 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jezyk MR |
| Year: |
2006 |
| Journal: |
Nat Struct Mol Biol |
| Title: |
Crystal structure of Rac1 bound to its effector phospholipase C-beta2. |
| Volume: |
13 |
| Issue: |
12 |
| Pages: |
1135-40 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
GAP1 (GTPase-activating protein 1) family members include RASA2 (GAP1m), RASAL (RASAL1), GAP1(IP4BP or RASA3), and CAPRI (RASA4). They all display Ras GAP activity. With the exception of RASA2, they all possess an arginine finger-dependent GAP activity on Rap1 [, ]. They contain N-terminal tandem C2 domain repeats, a centrally located Ras-GAP domain, and a PH (pleckstrin homology) domain containing a Btk motif [].RASAL, like Ca2+ -promoted Ras inactivator (CAPRI, or RASAL4), is a cytosolic protein that undergoes a rapid translocation to the plasma membrane in response to receptor-mediated elevation in the concentration of intracellular free Ca2+, a translocation that activates its ability to function as a RasGAP. However, unlike RASAL4, RASAL undergoes an oscillatory translocation to the plasma membrane that occurs in synchrony with repetitive Ca2+ spikes. Its tandem C2 domains bind phospholipids upon an elevation in the intracellular free Ca2+ concentration ([Ca2+]i) []. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Synaptotagmin-13 (SYT13) belongs to the synaptotagmin family, which is a group of membrane-trafficking proteins that contain two C-terminal C2 domains (known as C2A and C2B domains). Most of the synaptotagmins have a unique N-terminal domain (transmembrane region) that is involved in membrane anchoring or specific ligand binding. Unlike most of the synaptotagmins, SYT13 does not have an N-terminal transmembrane region. Its C2 domains are lacking almost all the residues involved in Ca2+ binding []. It is highly expressed in brain and also detectable at lower levels in non-neuronal tissues []. SYT13 can suppress liver tumour cells and this function may be mediated through pathways implicated in mesenchymal to epithelial transition []. It also affects insulin secretion []. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
This entry represents the novel protein kinase C (nPKC) family.The N-terminal regulatory domain of nPKC consists of a C2 domain follows by a double C1 domain (C1A and C1B). The C2 domain does not respond to calcium which makes nPKC diacylglycerol-sensitive but calcium-independent [, , ].PKC is a family of serine- and threonine-specific protein kinases that depend on lipids for activity. They can be activated by calcium but have a requirement for the second messenger diacylglycerol [, ]. Members of this family play key regulatory roles in various cellular processes. Currently, there are ten isoforms of PKC which can be classified into classical (alpha, beta I, beta II, gamma), novel (delta, epsilon, eta, theta) and atypical (zeta, iota/lambda) types based on their primary structure and biochemical characteristics [, , ]. All PKCs contain a C-terminal kinase domain and an N-terminal regulatory domain. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Protein kinase C (PKC) theta is classified as a novel PKC (nPKC). PKC theta is involved in T-cell activation and survival [, , ].The N-terminal regulatory domain of nPKC consists of a C2 domain follows by a double C1 domain (C1A and C1B). The C2 domain does not respond to calcium which makes nPKC diacylglycerol-sensitive but calcium-independent [, , ].PKC is a family of serine- and threonine-specific protein kinases that depend on lipids for activity. They can be activated by calcium but have a requirement for the second messenger diacylglycerol [, ]. Members of this family play key regulatory roles in various cellular processes. Currently, there are ten isoforms of PKC which can be classified into classical (alpha, beta I, beta II, gamma), novel (delta, epsilon, eta, theta) and atypical (zeta, iota/lambda) types based on their primary structure and biochemical characteristics [, , ]. All PKCs contain a C-terminal kinase domain and an N-terminal regulatory domain. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents the catalytic domain of PI3K-C2-alpha, which is a Class II phosphoinositide-3-kinase (PI3K) that generates phosphatidylinositol 3-phosphate (PtdIns3P) and phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2). It plays key roles in clathrin assembly and clathrin-mediated membrane trafficking [], insulin signaling [], and vascular smooth muscle contraction [].PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class II PI3Ks preferentially use PtdIns as a substrate to produce PtdIns(3)P, but can also phosphorylate PtdIns(4)P. They function as monomers and do not associate with any regulatory subunits. Class II enzymes contain an N-terminal Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, an ATP-binding cataytic domain, a Phox homology (PX) domain, and a second C2 domain at the C terminus [, ]. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents the catalytic domain of PI3K-C2-gamma, which is a Class II phosphoinositide-3-kinase (PI3K) that generates phosphatidylinositol 3-phosphate (PtdIns3P) and phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2). PI3K-C2gamma is expressed in the liver, breast, and prostate []. PI3Ks can be divided into three main classes (I, II, and III), defined by their substrate specificity, regulation, and domain structure. Class I PI3Ks are the only enzymes capable of converting PtdIns(4,5)P2 to the critical second messenger PtdIns(3,4,5)P3. Class II PI3Ks preferentially use PtdIns as a substrate to produce PtdIns(3)P, but can also phosphorylate PtdIns(4)P. They function as monomers and do not associate with any regulatory subunits. Class II enzymes contain an N-terminal Ras binding domain, a lipid binding C2 domain, a PI3K homology domain of unknown function, an ATP-binding cataytic domain, a Phox homology (PX) domain, and a second C2 domain at the C terminus [, ]. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry corresponds to the MUN domain []found in Munc13 proteins. These constitute a family of three highly homologous molecules (Munc13-1, Munc13-2 and Munc13-3) with homology to Caenorhabditis elegans unc-13p. Munc13 proteins contain a phorbol ester-binding C1 domain and two C2 domains, which are Ca2+/phospholipid binding domains. Sequence analyses have uncovered two regions called Munc13 homology domains 1 (MHD1) and 2 (MHD2) that are arranged between two flanking C2 domains. MHD1 and MHD2 domains are present in a wide variety of proteins from Arabidopsis thaliana, C. elegans, Drosophila melanogaster, mouse, rat and human, some of which may function in a Munc13-like manner to regulate membrane trafficking. Structural studies have defined MHD1 and MHD2 to be part of the larger MUN domain which forms an elongated structure composed of any pairs of alpha helices. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
The MD-2-related lipid-recognition (ML) domain is implicated in lipid recognition, particularly in the recognition of pathogen related products. It has an immunoglobulin-like β-sandwich fold similar to that of E-set Ig domains. This domain is present in proteins from plants, animals and fungi, including the following proteins:Epididymal secretory protein E1 (also known as Niemann-Pick C2 protein - Npc2), which is known to bind cholesterol. Niemann-Pick disease type C2 is a fatal hereditary disease characterised by accumulation of low-density lipoprotein-derived cholesterol in lysosomes [].House-dust mite allergen proteins such as Der f 2 from Dermatophagoides farinae and Der p 2 from Dermatophagoides pteronyssinus [].This entry refers to the ML domain found in metazoan Npc2 as well and some similar proteins. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
The MD-2-related lipid-recognition (ML) domain is implicated in lipid recognition, particularly in the recognition of pathogen related products. It has an immunoglobulin-like β-sandwich fold similar to that of E-set Ig domains. This domain is present in proteins from plants, animals and fungi, including the following proteins:Epididymal secretory protein E1 (also known as Niemann-Pick C2 protein - Npc2), which is known to bind cholesterol. Niemann-Pick disease type C2 is a fatal hereditary disease characterised by accumulation of low-density lipoprotein-derived cholesterol in lysosomes [].House-dust mite allergen proteins such as Der f 2 from Dermatophagoides farinae and Der p 2 from Dermatophagoides pteronyssinus [].This entry refers to the ML domain found in phosphatidylinositol/phosphatidylglycerol transfer protein (PG/PI-TP). PG/PI-TP has been shown to bind phosphatidylglycerol and phosphatidylinositol, but the biological significance of this is still obscure []. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
PLC-beta (PLCbeta) is regulated by heterotrimeric G protein-coupled receptors through their C2 domain and long C-terminal extension which forms an autoinhibitory helix. There are four isoforms: PLC-beta1-4. These isoforms mediate the production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) to propagate signals for several physiological responses [, ].PLC-beta consists of an N-terminal PH domain, a EF hand domain, a catalytic domain split into X and Y halves, a C2 domain and a C-terminal PDZ. This entry represents the PH domain of PLC-beta. The PH domain of PLC-beta2 and PLC-beta3 plays a dual role, much like PLC-delta1, by binding to the plasma membrane, as well as the interaction site for the catalytic activator []. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
López-Juárez A |
| Year: |
2011 |
| Journal: |
Glia |
| Title: |
Expression of LPP3 in Bergmann glia is required for proper cerebellar sphingosine-1-phosphate metabolism/signaling and development. |
| Volume: |
59 |
| Issue: |
4 |
| Pages: |
577-89 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chiu YH |
| Year: |
2009 |
| Journal: |
Hum Mol Genet |
| Title: |
Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy. |
| Volume: |
18 |
| Issue: |
11 |
| Pages: |
1976-89 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Johnson JL |
| Year: |
2011 |
| Journal: |
Infect Immun |
| Title: |
Increased survival and reduced neutrophil infiltration of the liver in Rab27a- but not Munc13-4-deficient mice in lipopolysaccharide-induced systemic inflammation. |
| Volume: |
79 |
| Issue: |
9 |
| Pages: |
3607-18 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Monfregola J |
| Year: |
2012 |
| Journal: |
J Biol Chem |
| Title: |
MUNC13-4 protein regulates the oxidative response and is essential for phagosomal maturation and bacterial killing in neutrophils. |
| Volume: |
287 |
| Issue: |
53 |
| Pages: |
44603-18 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zou X |
| Year: |
2008 |
| Journal: |
Mol Immunol |
| Title: |
Removal of the BiP-retention domain in Cmicro permits surface deposition and developmental progression without L-chain. |
| Volume: |
45 |
| Issue: |
13 |
| Pages: |
3573-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Matheson LS |
| Year: |
2009 |
| Journal: |
Int Immunol |
| Title: |
Light chain-deficient mice produce novel multimeric heavy-chain-only IgA by faulty class switching. |
| Volume: |
21 |
| Issue: |
8 |
| Pages: |
957-66 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Weißert K |
| Year: |
2022 |
| Journal: |
EMBO Mol Med |
| Title: |
Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH). |
| Volume: |
14 |
| Issue: |
12 |
| Pages: |
e16085 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cacciottolo M |
| Year: |
2011 |
| Journal: |
J Biol Chem |
| Title: |
Reverse engineering gene network identifies new dysferlin-interacting proteins. |
| Volume: |
286 |
| Issue: |
7 |
| Pages: |
5404-13 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Terrill JR |
| Year: |
2013 |
| Journal: |
FEBS J |
| Title: |
Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies. |
| Volume: |
280 |
| Issue: |
17 |
| Pages: |
4149-64 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Besseyrias V |
| Year: |
2007 |
| Journal: |
J Exp Med |
| Title: |
Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. |
| Volume: |
204 |
| Issue: |
2 |
| Pages: |
331-43 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Varnum-Finney B |
| Year: |
2011 |
| Journal: |
J Clin Invest |
| Title: |
Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells. |
| Volume: |
121 |
| Issue: |
3 |
| Pages: |
1207-16 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Restivo G |
| Year: |
2011 |
| Journal: |
EMBO J |
| Title: |
IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes. |
| Volume: |
30 |
| Issue: |
22 |
| Pages: |
4571-85 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gómez-López S |
| Year: |
2016 |
| Journal: |
Sci Rep |
| Title: |
Neural ablation of the PARK10 candidate Plpp3 leads to dopaminergic transmission deficits without neurodegeneration. |
| Volume: |
6 |
|
| Pages: |
24028 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Komiyama NH |
| Year: |
2002 |
| Journal: |
J Neurosci |
| Title: |
SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. |
| Volume: |
22 |
| Issue: |
22 |
| Pages: |
9721-32 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Porter K |
| Year: |
2005 |
| Journal: |
Eur J Neurosci |
| Title: |
Differential expression of two NMDA receptor interacting proteins, PSD-95 and SynGAP during mouse development. |
| Volume: |
21 |
| Issue: |
2 |
| Pages: |
351-62 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhang J |
| Year: |
2019 |
| Journal: |
Autophagy |
| Title: |
Cross-regulation of defective endolysosome trafficking and enhanced autophagy through TFEB in UNC13D deficiency. |
| Volume: |
15 |
| Issue: |
10 |
| Pages: |
1738-1756 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kindlmann GL |
| Year: |
2005 |
| Journal: |
Mol Imaging |
| Title: |
Practical vessel imaging by computed tomography in live transgenic mouse models for human tumors. |
| Volume: |
4 |
| Issue: |
4 |
| Pages: |
417-24 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kashiwagi Y |
| Year: |
2019 |
| Journal: |
Nat Commun |
| Title: |
Computational geometry analysis of dendritic spines by structured illumination microscopy. |
| Volume: |
10 |
| Issue: |
1 |
| Pages: |
1285 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mountford JK |
| Year: |
2015 |
| Journal: |
Nat Commun |
| Title: |
The class II PI 3-kinase, PI3KC2α, links platelet internal membrane structure to shear-dependent adhesive function. |
| Volume: |
6 |
|
| Pages: |
6535 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Li J |
| Year: |
2021 |
| Journal: |
J Immunol |
| Title: |
Elucidating the Motif for CpG Oligonucleotide Binding to the Dendritic Cell Receptor DEC-205 Leads to Improved Adjuvants for Liver-Resident Memory. |
| Volume: |
207 |
| Issue: |
7 |
| Pages: |
1836-1847 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Schumacher D |
| Year: |
2013 |
| Journal: |
Cancer Cell |
| Title: |
Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. |
| Volume: |
24 |
| Issue: |
1 |
| Pages: |
130-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Crozat K |
| Year: |
2011 |
| Journal: |
Blood |
| Title: |
Impact of β2 integrin deficiency on mouse natural killer cell development and function. |
| Volume: |
117 |
| Issue: |
10 |
| Pages: |
2874-82 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zou X |
| Year: |
2003 |
| Journal: |
J Immunol |
| Title: |
Block in development at the pre-B-II to immature B cell stage in mice without Ig kappa and Ig lambda light chain. |
| Volume: |
170 |
| Issue: |
3 |
| Pages: |
1354-61 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bahar Halpern K |
| Year: |
2020 |
| Journal: |
Nat Commun |
| Title: |
Lgr5+Â telocytes are a signaling source at the intestinal villus tip. |
| Volume: |
11 |
| Issue: |
1 |
| Pages: |
1936 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Thorne CA |
| Year: |
2018 |
| Journal: |
Dev Cell |
| Title: |
Enteroid Monolayers Reveal an Autonomous WNT and BMP Circuit Controlling Intestinal Epithelial Growth and Organization. |
| Volume: |
44 |
| Issue: |
5 |
| Pages: |
624-633.e4 |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Pax3/Pax3<+> Tg(CMV-cre)1Cgn/? |
| Background: |
involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6 |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Pax3/Pax3<+> Pax7/Pax7<+> |
| Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Dlg4/Dlg4 Syngap1/Syngap1<+> |
| Background: |
involves: 129P2/OlaHsd * MF1 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Notch1/Notch1<+> Notch2/Notch2<+> Tg(Tyr-cre)2Lru/? |
| Background: |
involves: 129 * BALB/c * C57BL/6 * DBA/2 |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Notch1/Notch1<+> Notch2/Notch2 Tg(Tyr-cre)2Lru/? |
| Background: |
involves: 129 * BALB/c * C57BL/6 * DBA/2 |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Notch1/Notch1 Notch2/Notch2<+> Tg(Tyr-cre)2Lru/? |
| Background: |
involves: 129/Sv * BALB/c * C57BL/6 * DBA/2 |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Notch1/Notch1 Notch2/Notch2 Tg(Tyr-cre)2Lru/? |
| Background: |
involves: 129 * BALB/c * C57BL/6 * DBA/2 |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Notch1/Notch1 Notch2/Notch2 Tg(Mx1-cre)1Cgn/? |
| Background: |
involves: 129 * BALB/c * C57BL/6 * CBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Notch1/Notch1 Notch2/Notch2 Ptf1a/Ptf1a<+> |
| Background: |
involves: 129 * BALB/cJ |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Myf6/Myf6<+> Pax3/Pax3 Trp53/Trp53<+> |
| Background: |
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Myf6/Myf6<+> Pax3/Pax3 Trp53/Trp53 |
| Background: |
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a Myf6/Myf6<+> Pax3/Pax3 |
| Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Myf6/Myf6<+> Pax3/Pax3<+> |
| Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tcra/Tcra Tg(Mx1-cre)1Cgn/? |
| Background: |
involves: C57BL/6 * CBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Dysf/Dysf Fktn/Fktn |
| Background: |
involves: 129S7/SvEvBrd * C57BL/6 * SJL/J |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Dysf/Dysf<+> Fktn/Fktn |
| Background: |
involves: 129S7/SvEvBrd * C57BL/6 * SJL/J |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Dysf/Dysf Fktn/Fktn<+> |
| Background: |
involves: C57BL/6 * SJL/J |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Dysf/Dysf<+> Large1/Large1 |
| Background: |
involves: C57BL/6 * SJL/J |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Dysf/Dysf Large1/Large1 |
| Background: |
involves: C57BL/6 * SJL/J |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Ihh/Ihh Lgr5/Lgr5<+> |
| Background: |
involves: 129S/SvEv * C57BL/6NTac * ICR |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Veith AM |
| Year: |
2006 |
| Journal: |
Genomics |
| Title: |
Male-biased expression of X-chromosomal DM domain-less Dmrt8 genes in the mouse. |
| Volume: |
88 |
| Issue: |
2 |
| Pages: |
185-95 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fernández-Chacón R |
| Year: |
2001 |
| Journal: |
Nature |
| Title: |
Synaptotagmin I functions as a calcium regulator of release probability. |
| Volume: |
410 |
| Issue: |
6824 |
| Pages: |
41-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fukuda M |
| Year: |
2002 |
| Journal: |
J Biol Chem |
| Title: |
Synaptotagmin IX regulates Ca2+-dependent secretion in PC12 cells. |
| Volume: |
277 |
| Issue: |
7 |
| Pages: |
4601-4 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
88
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nalefski EA |
| Year: |
1994 |
| Journal: |
J Biol Chem |
| Title: |
Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca(2+)-dependent lipid-binding domain and a Ca(2+)-independent catalytic domain. |
| Volume: |
269 |
| Issue: |
27 |
| Pages: |
18239-49 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lee KS |
| Year: |
1994 |
| Journal: |
J Biol Chem |
| Title: |
The Saccharomyces cerevisiae PLB1 gene encodes a protein required for lysophospholipase and phospholipase B activity. |
| Volume: |
269 |
| Issue: |
31 |
| Pages: |
19725-30 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Geppert M |
| Year: |
1991 |
| Journal: |
J Biol Chem |
| Title: |
Synaptotagmin II. A novel differentially distributed form of synaptotagmin. |
| Volume: |
266 |
| Issue: |
21 |
| Pages: |
13548-52 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sundberg E |
| Year: |
1999 |
| Journal: |
Nat Struct Biol |
| Title: |
Structural basis for HLA-DQ binding by the streptococcal superantigen SSA. |
| Volume: |
6 |
| Issue: |
2 |
| Pages: |
123-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chi YI |
| Year: |
2002 |
| Journal: |
J Biol Chem |
| Title: |
Zinc-mediated dimerization and its effect on activity and conformation of staphylococcal enterotoxin type C. |
| Volume: |
277 |
| Issue: |
25 |
| Pages: |
22839-46 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hâkansson M |
| Year: |
2000 |
| Journal: |
J Mol Biol |
| Title: |
The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules. |
| Volume: |
302 |
| Issue: |
3 |
| Pages: |
527-37 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Schad EM |
| Year: |
1995 |
| Journal: |
EMBO J |
| Title: |
Crystal structure of the superantigen staphylococcal enterotoxin type A. |
| Volume: |
14 |
| Issue: |
14 |
| Pages: |
3292-301 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Arcus VL |
| Year: |
2000 |
| Journal: |
J Mol Biol |
| Title: |
Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes. |
| Volume: |
299 |
| Issue: |
1 |
| Pages: |
157-68 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Earhart CA |
| Year: |
2000 |
| Journal: |
Protein Sci |
| Title: |
Structure of streptococcal pyrogenic exotoxin A reveals a novel metal cluster. |
| Volume: |
9 |
| Issue: |
9 |
| Pages: |
1847-51 |
|
•
•
•
•
•
|